Response to HAART according to sex and origin (immigrant vs autochthonous) in a cohort of patients who initiate antiretroviral treatment

Table 1

	WOMEN (318)	MEN (772)	P
Immigrants, %	45.6	31.1	<0.001
Age, years (IQR)	35 (29-41)	39 (33-44)	<0.001
Median viral load (IQR)/CD4 (IQR)	4.7 (4.2-5.2)/ 217 (113-300)	5.0 (4.5-5.4)/ 190 (69-280)	0.001/0.002
Coinfection with HBV or HCV %	25.2	29.3	0.32
Stage C/Late diagnosis, %	21.2/49.0	29.0/59.0	0.006/0.003
Median time from diagnosis of HIV infection to initiation of HAART, mo (IQR)	15 (2-43)	16 (2-49)	0.55
Median TTF, wk	147	171	<0.001
VF/OI, %	5.3	6.3	0.52

Educational level and occupational status were significantly poorer in women. The adjusted risk of treatment failure in women was not significantly different from that of men (HR, 1.101; 95% CI, 0.79-1.53). The increase in CD4 lymphocytes was equivalent (185 vs 205). TTF was shorter among (IW) than autochthonous women (AW): 124 weeks (95% CI, 64-183) vs 152 (95% CI, 127-174). Most immigrant women were African and Latin American, and their dropout rate (25.5 vs 11.6) was double that of AW.